CARRIER-MEDIATED TRANSPORT OF H-1-ANTAGONIST AT THE BLOOD-BRAIN-BARRIER - A COMMON TRANSPORT-SYSTEM OF H-1-ANTAGONISTS AND LIPOPHILIC BASICDRUGS

Citation
M. Yamazaki et al., CARRIER-MEDIATED TRANSPORT OF H-1-ANTAGONIST AT THE BLOOD-BRAIN-BARRIER - A COMMON TRANSPORT-SYSTEM OF H-1-ANTAGONISTS AND LIPOPHILIC BASICDRUGS, Pharmaceutical research, 11(11), 1994, pp. 1516-1518
Citations number
6
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
07248741
Volume
11
Issue
11
Year of publication
1994
Pages
1516 - 1518
Database
ISI
SICI code
0724-8741(1994)11:11<1516:CTOHAT>2.0.ZU;2-9
Abstract
The blood-brain barrier (BBB) transport system for H-1-antagonists was studied using primary cultured bovine brain capillary endothelial cel ls (BCEC). The uptake of [H-3]mepyramine was inhibited by various H-1- antagonists. Ketotifen competitively inhibited [H-3]mepyramine uptake with an inhibition constant (K-i) of 46.8 mu M. Lipophilic basic drugs such as propranolol, lidocaine and imipramine significantly inhibited [H-3]mepyramine uptake. In particular, propranolol inhibited [H-3]mep yramine uptake competitively at an inhibition constant (K-i) of 51.1 m u M. Moreover, in ATP-depleted BCEC, [H-3]mepyramine uptake was stimul ated by preloading with H-1-antagonists and lipophilic basic drugs. Th ese results indicated that H-1-antagonists are transported across the BBB via a carrier-mediated transport system common to lipophilic basic drugs.